Skip to main content
AAPL+0.69%MSFT+0.96%GOOGL+1.78%NVDA+3.63%AMZN+1.69%SPCX+1.42%TSM+2.78%AVGO+2.47%META+1.21%TSLA+1.46%LLY+0.01%WMT+0.08%JPM-0.04%BRK-B0.00%V+0.01%SKHY0.00%AMD+3.30%MU+2.48%XOM0.00%JNJ+0.15%MA-0.02%ABBV+0.08%ASMLa-9.33%COST+0.19%1398.HK+0.25%KO+0.03%CVX+0.03%0700.HK-1.26%PG+0.09%CSCO+0.07%0939.HK0.00%HD+0.05%3988.HK-1.13%BAC+0.05%1816.HK+3.45%GE-0.03%0857.HK-0.49%ORCL-0.01%UNH+0.01%1288.HK-0.45%PM+0.02%0005.HK-3.08%NVS-0.01%HSBA.L-3.62%INTC+3.30%AZN-0.01%MS+0.02%RTX+0.02%ORp-0.36%TMO+0.14%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%CADJPY0.00%CHFJPY0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURPLN0.00%NZDJPY0.00%CHFNOK0.00%EURDKK0.00%NZDMXN0.00%GBPSGD0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.22%ETHUSD+71.01%USDTUSD+0.12%XRPUSD+61.26%SOLUSD+68.72%TRXUSDT+0.20%ZECUSDT+2.26%XMRUSDT-0.11%DOGEUSD+69.80%LINKUSD+2.87%XLMUSD-0.66%BCHUSDT-0.65%LTCUSD+68.40%UNIUSD-0.38%TONUSD+79.92%SUIUSD+1.76%HBARUSDT+0.13%TAOUSDT+2.25%AAVEUSD+1.48%ONDOUSDT+1.12%DOTUSDT+1.61%ICPUSDT+2.94%WLDUSDT+3.76%ARBUSDT+2.09%ATOMUSDT-0.07%INJUSDT+4.12%STXUSDT+2.99%PYTHUSDT+4.63%TIAUSDT+3.05%FETUSDT+0.01%SEIUSDT+0.59%JUPUSDT+3.25%GRTUSDT+0.76%OPUSDT+1.55%IOTAUSDT+2.04%POLUSDT+0.60%WIFUSDT+1.51%AXSUSDT+0.09%EOSUSDT+0.60%IMXUSDT+0.09%FARTCOINUSDT+1.18%GALAUSDT+3.50%DYDXUSDT+0.13%ORDIUSDT+2.66%NOTUSDT+1.19%RONINUSDT+1.91%AAPL+0.69%MSFT+0.96%GOOGL+1.78%NVDA+3.63%AMZN+1.69%SPCX+1.42%TSM+2.78%AVGO+2.47%META+1.21%TSLA+1.46%LLY+0.01%WMT+0.08%JPM-0.04%BRK-B0.00%V+0.01%SKHY0.00%AMD+3.30%MU+2.48%XOM0.00%JNJ+0.15%MA-0.02%ABBV+0.08%ASMLa-9.33%COST+0.19%1398.HK+0.25%KO+0.03%CVX+0.03%0700.HK-1.26%PG+0.09%CSCO+0.07%0939.HK0.00%HD+0.05%3988.HK-1.13%BAC+0.05%1816.HK+3.45%GE-0.03%0857.HK-0.49%ORCL-0.01%UNH+0.01%1288.HK-0.45%PM+0.02%0005.HK-3.08%NVS-0.01%HSBA.L-3.62%INTC+3.30%AZN-0.01%MS+0.02%RTX+0.02%ORp-0.36%TMO+0.14%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%CADJPY0.00%CHFJPY0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURPLN0.00%NZDJPY0.00%CHFNOK0.00%EURDKK0.00%NZDMXN0.00%GBPSGD0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.22%ETHUSD+71.01%USDTUSD+0.12%XRPUSD+61.26%SOLUSD+68.72%TRXUSDT+0.20%ZECUSDT+2.26%XMRUSDT-0.11%DOGEUSD+69.80%LINKUSD+2.87%XLMUSD-0.66%BCHUSDT-0.65%LTCUSD+68.40%UNIUSD-0.38%TONUSD+79.92%SUIUSD+1.76%HBARUSDT+0.13%TAOUSDT+2.25%AAVEUSD+1.48%ONDOUSDT+1.12%DOTUSDT+1.61%ICPUSDT+2.94%WLDUSDT+3.76%ARBUSDT+2.09%ATOMUSDT-0.07%INJUSDT+4.12%STXUSDT+2.99%PYTHUSDT+4.63%TIAUSDT+3.05%FETUSDT+0.01%SEIUSDT+0.59%JUPUSDT+3.25%GRTUSDT+0.76%OPUSDT+1.55%IOTAUSDT+2.04%POLUSDT+0.60%WIFUSDT+1.51%AXSUSDT+0.09%EOSUSDT+0.60%IMXUSDT+0.09%FARTCOINUSDT+1.18%GALAUSDT+3.50%DYDXUSDT+0.13%ORDIUSDT+2.66%NOTUSDT+1.19%RONINUSDT+1.91%
DM

Disc Medicine, Inc. (IRON)

NASDAQ • Healthcare

$75.14
-$0.96 (-1.3%)
Market open

Last close at November 20, 2026 at 21:00 UTC

Open$75.2
Previous Close$75.14
Day Range$74.54 - $77.01
Avg. Volume (3M)942.8K
Market Cap$2.8B
52 Week Range
$40$99.5

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$243.1M
EPS (TTM)
-$6.36
ROA (TTM)
-34.75%
Current Ratio
20.3

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-6.5%Q2 2026-$1.65
+9.9%Q3 2026-$1.54
+6.1%Q4 2026-$1.53

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +6.1%

Disc Medicine’s preliminary results for the third fiscal quarter of 2026 topped consensus on EPS, with -$1.53 coming in ahead of the -$1.63 estimate by $0.10, based on results reported November 5, 2026. The quarter’s GAAP net loss narrowed to roughly -$59.5 million, a +5% year-over-year improvement from about -$62.3 million, while EPS improved +14% from -$1.77 a year ago. Profitability remained negative, with operating income around -$64.2 million, and cash generation was also negative as operating cash flow was roughly -$40.2 million. For the next period, consensus calls for EPS of -$1.67 on revenue of $3.7 million.

View full earnings history

About Disc Medicine, Inc.

Disc Medicine, Inc. is a NASDAQ-listed Biotechnology company in the healthcare sector focused on therapies for red blood cell biology. Trading under the ticker IRON, it works on diseases tied to heme biosynthesis and iron homeostasis. In qualitative terms, Disc Medicine is a clinical-stage biotech.

Name
Disc Medicine, Inc.
CEO
John D. Quisel
Industry
Healthcare
Employees
165

Today's Snapshot

AI-generated

IRON closed 1.3% lower at 75.14, while its sector was flat. Volume was about two-thirds of its usual level. Zacks, a stock-ranking firm, raised Disc Medicine to a Buy rating.

Trading Volume

Below 10d avg (853.7K)

561.6K

vs S&P 500 Today

Outperforming Market

+2.22%

Updated: November 20, 2026 at 21:20 UTC

Technical Indicators

3 Buy2 Neutral3 Sell
IRON shows a neutral technical stance with conflicting signals: trend strength is modestly positive, yet short-term momentum and 10–20 day averages are below the market price. Longer-term moving averages (50/100/200) are beneath the current level, suggesting broader support, while CCI and momentum readings are negative and RSI sits near neutral. ATR is elevated at just over 5%, implying higher intraday movement, and the classic pivot around 77 sits above the current price as resistance. Technical takeaway: Neutral — mixed short-term weakness against longer-term support.
All signals
  • EMA (5 indicators)$73.43 - $78.23
    Sell
  • RSI (14)46.81
    Neutral
  • Stochastic %K (14, 3, 3)11.30
    Buy
  • MACD Level (12, 26)1.26
    Neutral

Peers & Related Assets

PTGXProtagonist Therapeutics, Inc.
$121.4-2.1%
AGIOAgios Pharmaceuticals, Inc.
$27.6-4.0%
GERNGeron Corporation
$0.87-4.6%
COAGHemab Therapeutics Holdings, Inc. Common Stock
DMRADamora Therapeutics, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.